The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system

<p>Abstract</p> <p>Background</p> <p>Previous studies have demonstrated that intrathecal administration of the substance P amino-terminal metabolite substance P<sub>1-7 </sub>(SP<sub>1-7</sub>) and its C-terminal amidated congener induced antihyp...

Full description

Bibliographic Details
Main Authors: Ohsawa Masahiro, Carlsson Anna, Asato Megumi, Koizumi Takayuki, Nakanishi Yuki, Fransson Rebecca, Sandström Anja, Hallberg Mathias, Nyberg Fred, Kamei Junzo
Format: Article
Language:English
Published: SAGE Publishing 2011-10-01
Series:Molecular Pain
Subjects:
Online Access:http://www.molecularpain.com/content/7/1/85
id doaj-ccc08fe64b194aeea0183cc036ed81f1
record_format Article
spelling doaj-ccc08fe64b194aeea0183cc036ed81f12020-11-25T04:03:12ZengSAGE PublishingMolecular Pain1744-80692011-10-01718510.1186/1744-8069-7-85The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor systemOhsawa MasahiroCarlsson AnnaAsato MegumiKoizumi TakayukiNakanishi YukiFransson RebeccaSandström AnjaHallberg MathiasNyberg FredKamei Junzo<p>Abstract</p> <p>Background</p> <p>Previous studies have demonstrated that intrathecal administration of the substance P amino-terminal metabolite substance P<sub>1-7 </sub>(SP<sub>1-7</sub>) and its C-terminal amidated congener induced antihyperalgesic effects in diabetic mice. In this study, we studied a small synthetic dipeptide related to SP<sub>1-7 </sub>and endomorphin-2, i.e. Phe-Phe amide, using the tail-flick test and von Frey filament test in diabetic and non-diabetic mice.</p> <p>Results</p> <p>Intrathecal treatment with the dipeptide increased the tail-flick latency in both diabetic and non-diabetic mice. This effect of Phe-Phe amide was significantly greater in diabetic mice than non-diabetic mice. The Phe-Phe amide-induced antinociceptive effect in both diabetic and non-diabetic mice was reversed by the σ<sub>1 </sub>receptor agonist (+)-pentazocine. Moreover, Phe-Phe amide attenuated mechanical allodynia in diabetic mice, which was reversible by (+)-pentazocine. The expression of spinal σ1 receptor mRNA and protein did not differ between diabetic mice and non-diabetic mice. On the other hand, the expression of phosphorylated extracellular signal-regulated protein kinase 1 (ERK1) and ERK2 proteins was enhanced in diabetic mice. (+)-Pentazocine caused phosphorylation of ERK1 and ERK2 proteins in non-diabetic mice, but not in diabetic mice.</p> <p>Conclusions</p> <p>These results suggest that the spinal σ<sub>1 </sub>receptor system might contribute to diabetic mechanical allodynia and thermal hyperalgesia, which could be potently attenuated by Phe-Phe amide.</p> http://www.molecularpain.com/content/7/1/85AllodyniaAntinociceptionDiabetesHyperalgesiaOpioid receptorsPhe-Phe amideσ<sub>1 </sub>receptorSubstance P<sub>1-7</sub>
collection DOAJ
language English
format Article
sources DOAJ
author Ohsawa Masahiro
Carlsson Anna
Asato Megumi
Koizumi Takayuki
Nakanishi Yuki
Fransson Rebecca
Sandström Anja
Hallberg Mathias
Nyberg Fred
Kamei Junzo
spellingShingle Ohsawa Masahiro
Carlsson Anna
Asato Megumi
Koizumi Takayuki
Nakanishi Yuki
Fransson Rebecca
Sandström Anja
Hallberg Mathias
Nyberg Fred
Kamei Junzo
The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system
Molecular Pain
Allodynia
Antinociception
Diabetes
Hyperalgesia
Opioid receptors
Phe-Phe amide
σ<sub>1 </sub>receptor
Substance P<sub>1-7</sub>
author_facet Ohsawa Masahiro
Carlsson Anna
Asato Megumi
Koizumi Takayuki
Nakanishi Yuki
Fransson Rebecca
Sandström Anja
Hallberg Mathias
Nyberg Fred
Kamei Junzo
author_sort Ohsawa Masahiro
title The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system
title_short The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system
title_full The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system
title_fullStr The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system
title_full_unstemmed The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system
title_sort dipeptide phe-phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system
publisher SAGE Publishing
series Molecular Pain
issn 1744-8069
publishDate 2011-10-01
description <p>Abstract</p> <p>Background</p> <p>Previous studies have demonstrated that intrathecal administration of the substance P amino-terminal metabolite substance P<sub>1-7 </sub>(SP<sub>1-7</sub>) and its C-terminal amidated congener induced antihyperalgesic effects in diabetic mice. In this study, we studied a small synthetic dipeptide related to SP<sub>1-7 </sub>and endomorphin-2, i.e. Phe-Phe amide, using the tail-flick test and von Frey filament test in diabetic and non-diabetic mice.</p> <p>Results</p> <p>Intrathecal treatment with the dipeptide increased the tail-flick latency in both diabetic and non-diabetic mice. This effect of Phe-Phe amide was significantly greater in diabetic mice than non-diabetic mice. The Phe-Phe amide-induced antinociceptive effect in both diabetic and non-diabetic mice was reversed by the σ<sub>1 </sub>receptor agonist (+)-pentazocine. Moreover, Phe-Phe amide attenuated mechanical allodynia in diabetic mice, which was reversible by (+)-pentazocine. The expression of spinal σ1 receptor mRNA and protein did not differ between diabetic mice and non-diabetic mice. On the other hand, the expression of phosphorylated extracellular signal-regulated protein kinase 1 (ERK1) and ERK2 proteins was enhanced in diabetic mice. (+)-Pentazocine caused phosphorylation of ERK1 and ERK2 proteins in non-diabetic mice, but not in diabetic mice.</p> <p>Conclusions</p> <p>These results suggest that the spinal σ<sub>1 </sub>receptor system might contribute to diabetic mechanical allodynia and thermal hyperalgesia, which could be potently attenuated by Phe-Phe amide.</p>
topic Allodynia
Antinociception
Diabetes
Hyperalgesia
Opioid receptors
Phe-Phe amide
σ<sub>1 </sub>receptor
Substance P<sub>1-7</sub>
url http://www.molecularpain.com/content/7/1/85
work_keys_str_mv AT ohsawamasahiro thedipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem
AT carlssonanna thedipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem
AT asatomegumi thedipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem
AT koizumitakayuki thedipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem
AT nakanishiyuki thedipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem
AT franssonrebecca thedipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem
AT sandstromanja thedipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem
AT hallbergmathias thedipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem
AT nybergfred thedipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem
AT kameijunzo thedipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem
AT ohsawamasahiro dipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem
AT carlssonanna dipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem
AT asatomegumi dipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem
AT koizumitakayuki dipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem
AT nakanishiyuki dipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem
AT franssonrebecca dipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem
AT sandstromanja dipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem
AT hallbergmathias dipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem
AT nybergfred dipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem
AT kameijunzo dipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem
_version_ 1724441256302477312